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 A B S T R A CT   
Thymic epithelial neoplasms consist of thymomas, thymic carcinoids and thymic carcinomas. 
Carcinomas are malignant tumors of the thymus; they compromise only 4%-14% of thymic epithelial 
neoplasms. Thymic carcinoma cells do not resemble healthy cells but similar to cancer cells that 
originate from other parts of the body and grow more quickly when the tumor is found and more 
difficult to treat. Thymic carcinoma rarely occurs in children. We reported a case of undifferentiated 
thymic carcinoma in 11 months old female. After two courses of chemotherapy the patient developed 
increasing respiratory compression and unfortunately died because of respiratory failure. 
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1 Case Report 
11 months old infant presented to our 
consultation department as a referred case from 
pediatric teaching hospital as a case of anterior 
mediastinal mass, the mother gave a history of flu 
like illness since 1 months that lasted 3 days 
without any treatment after that the baby 
developed elevation in body temperature that’s 
why they consulted a consultant pediatrician who 
admitted her to the pediatric ward and treated as 
a case of bronchiolitis, she was admitted in 
hospital for 1 week and then discharged with 
some improvement on oral treatment but 
unfortunately the baby after two days again 
developed high grade fever in deterioration of the 
cough in severity and frequency and associated 
with shortness of breath that’s why the doctor 
sent a CXR and complete investigations which 
revealed a big anterior mediastinal mass which 
was suspicious to the pediatrician ,who send her 
to chest CT scan which confirmed what is seen 
in the CXR report, after that the patient  was 
referred for a cardiothoracic surgeon for further 
management who took a biopsy of the mass and 
sent her to our hospital ,we admitted the patient 
and started work up by sending full investigations 
including all blood tests and also review of the 
slide for histopathology and 
Immunohistochemistry confirmation. 
Regarding the antenatal history the mother was 
on very good antenatal care and the natal history 
the baby was delivered with cesarean section 
because of absent dilatations and in efficient 
contraction without any complication even not 
needed to enter the NCU. There is no known 
allergy to any drug, there is no history of 
operation and there is no family history of such a 
condition, the baby lives in a good 
socioeconomic status 
2 Physical Examination  
The child was ill locking, dysneic, tachypnic and 
pale. Vital signs are follows: 
PR: 100 b pm, RR: 40 /min, BP 110/70 mmhg, 
TEMP: 37.1C, SPO2:60 without O2 and 87 with O2, 
RBS: 128 mg/dl. 
No Lymphadenopathy, no organomegaly, no 
clubbing of finger, no jaundiced and auscultation of 
 54 
 
 ISSN: 2456-7132  
Available online at Journals.aijr.in 
Infant with Life Threatening Thymic Carcinoma 
the chest was decreased air entry in the right lung 
with fine crepitation   
We started supportive life saving measures by 
giving oxygen via nasal canula and steroids and 
sent for the following laboratory investigation- 
(complete blood count. blood film, electrolytes, 
tumor markers, ESR, CRP, LDH, ALP, coagulation 
factors viral screening, ferritin, acetyl choline 
esterase inhibitor antibody, and 24 hours urine for 
Vanillylmandelic Acid) also sent for imaging study 
which are CXR, echocardiography and abdominal 
ultrasound  
Results of laboratory investigation shows in 
Table 1. 
Table 1: Laboratory investigation results 
Investigation Result 
Hb:(hemoglobin) 10.6 g/dl 
WBC 6,300 cells per microliter 
Platelets Count 375,000 platelets/mcL 
ESR 47 mm/h 
CK 0.59 ukat/L 
CRP 13.2 mg/L 
LDH 391 IU-L 
Serum ferritin 72 ng/mL 
B-hcg <0.100mlU/ml 





24 Hour Urine VMA 1.00 mg/24h 
 
Regarding image study include CXR with a huge 
anterior mediastinal mass occupying most of 
right lung and part of left lung (Figure 1), 
abdominal US was normal, echocardiography 
was normal with Ejection fraction 74% and 
fractional shortening 42%. CT scan of chest with 
IV Iodine contrast reveal 8 * 5 cm mass lesion 
seen occupying most of the mediastinum and 
extending superiorly to the right side of neck, its 
displacing vessels including right pulmonary 
artery and SVC, it has large mass effect with 
partial collapse of the right lower lung and mild 
right side pleural effusion, the mass doesn’t show 
internal calcification or fatty tissue (Figure2)  
 
Figure 1: Anterior Posterior Chest X-ray Shows 
total collapse of right lung and part of left lung. 
 
 
Figure 2: Chest CT scan Shows large mass with 
partial right lung collapse. 
A biopsy by cardiothoracic surgeon from anterior 
mediastinal mass was performed as it was 
considered inoperable. Immunohistochemistry 
was done with positive controls shows the 
following reactions: 
AE1/AE3: positive, moderate staining for large cells 
EMA: positive  
CD79a: positive 
Negative for (Chromogranin, CD5, CD3, CD20, 
CD30, CD117, WT1, TDT, Myogenin, CD34, 
CD45, LCA, PLAP and Vimentin); negative 
reaction to these markers exclude neural tumors, 
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lymphomas, leukemia, and large subset of germ 
cell tumor.  
As the patient diagnosed, we put him on steroid 
drug and next day we started neoadjuvant 
chemotherapy as first cycle included (cisplatin for 
1 day, etoposide for 3 days and doxorubicin for 2 
days) but because the patient is not so stable, we 
modify chemotherapy to only 50%. 
At the beginning the radiation oncologist 
couldn’t give irradiation to the patient because of 
nearby to heart and other vital organs. Later on, 
she developed SVC syndrome which is caused by 
pressure effect of the tumor on the superior vena 
cava vein and they started irradiation to that site 
(1900 cGy). 
A second cycle of chemotherapy has been given 
after 21 days from first cycle which containing 
(etoposide, ifosfamide and cisplatin) but still no 
respond and couldn’t do surgical resection. After 
two courses of chemotherapy the patient 
developed increasing respiratory compression 
and unfortunately died because of respiratory 
failure. 
3 Discussion 
Thymic carcinoma rarely occurs in children. Only 
two pediatric cases were described in 19 
clinopathological studies including 305 cases 
analyzed by Chung [1]. we could ﬁnd only 14 
cases [2] in English literature. Thymic tumors 
account for 1.5% of mediastinal mass in children 
[3]. Thymic epithelial neoplasms represent a 
diverse group of tumors ranging from well 
differentiated thymomas to obviously malignant 
tumors [3], [4]. Thymic carcinoma has several 
subtypes which include squamous cell carcinoma, 
lymphoepithelioma like carcinoma, clear cell 
sarcoma, and undifferentiated thymic carcinoma 
[1], [4]–[7]. Myasthenia gravis and other 
paraneoplastic syndromes are rarely associated 
with thymic carcinoma unlike to thymoma [6], 
[8]. 
Thymic carcinoma arisen from epithelium and 
microscopically could be type B3 with round or 
polygonal shape or type C with many histological 
subtyping which includes squamous cell, 
lymphoepithelioma-like, sarcomatoid, clear cell, 
basaloid, mucoepidermoid, papillary and 
undifferentiated carcinoma. The World Health 
Organization in 2015 developed a classification 
of tumors of the thymus (Table2) [9]. 
Table 2: WHO classification. 
Type Histological description 
A Medullary thymoma. 
AB Mixed thymoma. 
B1 Predominantly cortical thymoma. 
B2 Cortical thymoma. 
B3 Well-differentiated thymic carcinoma. 
C Thymic carcinoma. 
 
Our patient has a histological subtype of 
undifferentiated carcinoma. Undifferentiated 
carcinoma some time also called anaplastic 
subtype associated with a highly aggressive 
behavior with poor prognosis [10]–[12]. The 
diagnosis of this subtype is one of exclusion, our 
patient was complaining of sever progressive 
dyspnea and low SPO2. CXR showed huge 
anterior mediastinal mass, CT scan showed 8 * 5 
cm mass lesion seen occupying most of the 
mediastinum and extending superiorly to the 
right side of neck, this manifestation is called 
superior vena cava syndrome which is caused by 
pressure effect of the tumor on the superior vena 
cava vein. 
3.1 We are Still using Masaoka Staging 
System for Thymic Carcinoma 
Stage 1: Completely encapsulated and 
microscopically no capsular invasion. 
Stage 2:  1. Macroscopic invasion into 
surrounding fatty tissue or mediastinal 
pleura  
2. Microscopic invasion into capsule 
Stage 3: Macroscopic invasion into neighboring 
organ, i.e., pericardium, great vessels, or 
lung  
Stage 4a:  pleural or pericardial dissemination  
Stage 4b:  lymphogenous or hematogenous 
metastasis 
Surgery is the primary treatment for thymic 
carcinoma with complete surgical resection as a 
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local control but because in most of patients 
surgery cannot be done at diagnosis due to local 
invasion of viable structures and metastasis, 
radiation used as a second line for local control 
and cisplatin based regimens have also proved to 
be effective in the treatment [1], [10], [13], [14]. 
Our patient was inoperable because of 
attachment to vital organ so we gave her radiation 
therapy (3500 cGy) and chemotherapy regimen 
containing cisplatin. After two courses of 
chemotherapy the patient developed increasing 
respiratory compression and unfortunately died 
because of respiratory failure. The prognosis of 
thymic carcinoma is poor [1], [10], [13], [14]. In 
summary thymic carcinoma although rare in 
infant age but we reported an 11 months old 
female with this aggressive tumor. 
4 Conclusion 
Thymic carcinoma is rare tumor of thymus and 
complete resection of tumor is the best way to 
achieve long term survival if feasible as a local 
control, our patient was inoperable, so we were 
started with radiotherapy and chemotherapy 
hopefully for getting better but the patient 
unfortunately died because a poor prognosis 
nature of thymic carcinoma in pediatric. Most 
thymic tumors in pediatric patients are inoperable 
at diagnosis, which results in poor prognosis. 
Improved chemotherapy approaches are needed. 
5 Abbreviations 
SVC: Superior Vena Cava; CT: Computed 
Tomography; CXR: Chest X-Ray; PR: Pulse Rate; 
RR: Respiratory Rate; BP: Blood Pressure;  
TEMP: Temperature; O2: Oxygen; RBS: Random 
Blood Sugar; ESR: Erythrocyte Sedimentation Rate; 
CK: Creatinine Kinase; CRP: C - reactive protein; 
LDH: Lactate Dehydrogenase; ALP: Alkaline 
Phosphatase; LFT: Liver Function Test; RFT: Renal 
Function Test; WBC: White Blood Test;  
gran: granulocyte; PLT: Platelet; NCU: Neonatal 
Care Unit; VMA: Vanillylmandelic Acid; AFP: Alpha 
Feto Protein; B-hCG: Beta Human Chorionic 
Gonadotropin; US: Ultrasonography;  
IV: Intravenous.  
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